Header Logo

Connection

NAVAL DAVER to Piperazines

Back to Details
This is a "connection" page, showing publications NAVAL DAVER has written about Piperazines.
NAVAL DAVER
Connection Strength
0.066
Piperazines
  1. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica. 2015 May; 100(5):653-61.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.